We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.6B
AUM Growth
+$769M
(+16%)
Cap. Flow
+$469M
Cap. Flow
% of AUM
8.38%
Top 10 Holdings %
Top 10 Hldgs %
13.16%
Holding
1,266
New
125
Increased
352
Reduced
429
Closed
264
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$58.9M |
| 2 |
EOG Resources
EOG
|
+$37.7M |
| 3 |
Yum! Brands
YUM
|
+$29.2M |
| 4 |
Agilent Technologies
A
|
+$25.5M |
| 5 |
Occidental Petroleum
OXY
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$27.1M |
| 2 |
Intercontinental Exchange
ICE
|
+$26M |
| 3 |
Global Payments
GPN
|
+$24.2M |
| 4 |
Cadence Design Systems
CDNS
|
+$22.8M |
| 5 |
Apple
AAPL
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.55% |
| 2 | Financials | 15.15% |
| 3 | Healthcare | 14.96% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Industrials | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KTEC
951
DELISTED
Key Technology Inc
KTEC
| $128K | ﹤0.01% |
11,649
-451
| -4% | -$4.66K |
|
952
OraSure Technologies
OSUR
$273M
| $127K | ﹤0.01% |
15,900
-25,200
| -61% | -$187K |
|
953
Ultralife
ULBI
$88.3M
| $126K | ﹤0.01% |
+30,551
| New | +$134K |
|
|
CTG
954
DELISTED
Computer Task Group, Inc.
CTG
| $126K | ﹤0.01% |
26,900
-11,366
| -30% | -$55.4K |
|
|
WG
955
DELISTED
Willbros Group
WG
| $123K | ﹤0.01% |
65,388
-35,712
| -35% | -$73.3K |
|
956
Townsquare Media
TSQ
$113M
| $119K | ﹤0.01% |
12,740
-5,293
| -29% | -$46.8K |
|
|
ARQL
957
DELISTED
Arqule Inc
ARQL
| $118K | ﹤0.01% |
65,803
-21,146
| -24% | -$33.5K |
|
958
Aviat Networks
AVNW
$262M
| $114K | ﹤0.01% |
24,454
| – | – |
|
959
Ameresco
AMRC
$1.15B
| $113K | ﹤0.01% |
21,500
-17,524
| -45% | -$86.8K |
|
|
FPO
960
DELISTED
First Potomac Realty Trust
FPO
| $107K | ﹤0.01% |
11,700
+500
| +4% | +$4.84K |
|
|
QUMU
961
DELISTED
Qumu Corp.
QUMU
| $101K | ﹤0.01% |
44,444
-10,280
| -19% | -$33.2K |
|
962
KVH Industries
KVHI
$177M
| $100K | ﹤0.01% |
11,300
| – | – |
|
|
TVIA
963
DELISTED
TerraVia Holdings, Inc. Common Stock
TVIA
| $99K | ﹤0.01% |
36,158
-249,442
| -87% | -$644K |
|
|
EGAS
964
DELISTED
Gas Natural Inc.
EGAS
| $99K | ﹤0.01% |
+12,901
| New | +$95.6K |
|
965
Lisata Therapeutics
LSTA
$15.2M
| $97K | ﹤0.01% |
1,394
-12
| -0.9% | -$967 |
|
|
HBP
966
DELISTED
Huttig Building Products, Inc.
HBP
| $97K | ﹤0.01% |
16,753
-2,300
| -12% | -$13.9K |
|
|
PSTB
967
DELISTED
Park Sterling Corp.
PSTB
| $90K | ﹤0.01% |
11,100
-6,400
| -37% | -$50.8K |
|
968
Mitek Systems
MITK
$762M
| $89K | ﹤0.01% |
10,700
| – | – |
|
969
Curis
CRIS
$9.53M
| $88K | ﹤0.01% |
17
-98
| -85% | -$359K |
|
|
RTK
970
DELISTED
Rentech, Inc.
RTK
| $86K | ﹤0.01% |
+29,457
| New | +$89.4K |
|
|
I
971
DELISTED
INTELSAT S. A.
I
| $85K | ﹤0.01% |
31,300
+4,200
| +15% | +$11.3K |
|
|
IMI
972
DELISTED
Intermolecular, Inc.
IMI
| $84K | ﹤0.01% |
84,345
-6,000
| -7% | -$7.39K |
|
|
YUME
973
DELISTED
YuMe, Inc.
YUME
| $81K | ﹤0.01% |
20,500
-61,026
| -75% | -$221K |
|
|
SRGA
974
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $80K | ﹤0.01% |
847
+257
| +44% | +$25.8K |
|
|
ARDM
975
DELISTED
Aradigm Corp Common Stock
ARDM
| $78K | ﹤0.01% |
11,300
-3,500
| -24% | -$17K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2016 Portfolio in Review
As of Q3 2016, Jacobs Levy Equity Management held 1,266 positions worth $5.6B, up 16% from $4.83B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management deployed $469M of net new capital in Q3 2016, opening 125 new positions and adding to 352 existing holdings. Its largest new stake was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Intercontinental Exchange, an estimated $26M trimmed.
- Jacobs Levy Equity Management's largest Q3 2016 buy was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
- Jacobs Levy Equity Management added most to Agilent Technologies in Q3 2016, an estimated $25.5M increase.
- Jacobs Levy Equity Management's biggest Q3 2016 reduction was Intercontinental Exchange, cutting an estimated $26M.
- Jacobs Levy Equity Management fully exited Gen Digital in Q3 2016, selling an estimated $27.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $5.6B portfolio in Q3 2016.
- Jacobs Levy Equity Management opened 125 new positions and closed 264 in Q3 2016.
- Jacobs Levy Equity Management's portfolio value rose 16% quarter-over-quarter to $5.6B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.